- $31.60m
- $33.61m
- $43.63m
- 56
- 72
- 58
- 65
R2019 December 31st | C2020 December 31st | 2021 December 31st | R2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 55.3 | 49.8 | 40.6 | 35.2 | 43.6 |
Cost of Revenue | |||||
Gross Profit | 12.1 | 8.24 | 5.99 | 5.57 | 7.8 |
Selling / General / Administrative Expenses | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 52.2 | 49.6 | 36.3 | 37.7 | 45.7 |
Operating Profit | 3.12 | 0.242 | 4.3 | -2.5 | -2.11 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | 3.12 | 0.062 | 4.01 | -2.67 | -2.45 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2.45 | 0.1 | 4.05 | -2.1 | -3.55 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 2.45 | 0.1 | 4.05 | -2.12 | -10.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 2.45 | 0.1 | 4.05 | -2.12 | -10.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.03 | 0.042 | -0.375 | -0.867 | -1.42 |
Dividends per Share |